Generate a tailored SOP for Dr. Petra Hajkova. Improve your application with a focused, well-structured draft.
Petra Hajkova is the Head of the Reprogramming Chromatin Research Group at the Medical Research Council, where she has been a Programme Leader since 2015 and involved in research since 2009. Her primary research focuses on understanding how epigenetic information is maintained over prolonged periods in differentiated cells and how this can be erased in the context of epigenetic reprogramming. She has held various leadership positions within the MRC London Institute of Medical Sciences, including serving as the Interim Director. Petra is a Fellow of the Academy of Medical Sciences and a member of the European Molecular Biology Organisation. Her work aims to merge scientific inquiry with real clinical problems, collaborating with colleagues in the unique environment of the Hammersmith Hospital campus.
Reprogramming Chromatin Research Group • London
Leading a research group focusing on the reprogramming of chromatin and its implications for cell identity and gene-environment interactions.
MRC-London Institute of Medical Sciences • London
Oversaw the activities of the institute and led various initiatives to enhance research collaborations.
MRC-London Institute of Medical Sciences • London
Conducted pioneering research in epigenetics, focusing on the mechanisms of chromatin reprogramming.